Aster DM Healthcare Limited has invested ₹25 crore to acquire 3,57,143 Optionally Convertible Redeemable Preference Shares (OCRPS) in its associate company, Alfaone Medicals Private Limited. The acquisition, completed on June 29, 2026, involved a subscription to a rights issue at a price of ₹700 per share, which includes a security premium of ₹690 per share. This strategic investment is intended for general corporate purposes within the healthcare sector.

The transaction was classified as a related party transaction since Alfaone Medicals is an associate of Aster DM Healthcare . The Board approved the deal, confirming it was conducted at arm’s length, with no interest held by the promoter or promoter group beyond the company’s existing stake. The consideration was paid in cash, and no specific governmental or regulatory approvals were required for the completion.

Alfaone Medicals Private Limited, incorporated on December 03, 2020, operates in the healthcare industry, specifically trading drugs and pharmaceuticals. The entity reported a turnover of ₹589.55 lakhs for the financial year ended March 31, 2026, compared to ₹616.32 lakhs in FY2024-25 and ₹621.79 lakhs in FY2023-24. The company is based in Bengaluru, Karnataka.

Following the allotment, Aster DM Healthcare’s holding in Alfaone Medicals consists of 11,50,941 equity shares, representing 48.91% of the equity share capital. The company now holds 37,54,243 OCRPS, which constitutes 100% of that class of shares. The total cost of acquisition was ₹25,00,00,100.

Financial Details of Acquisition

Alfaone Medicals Turnover History

Aster DM Healthcare has fixed July 9, 2026, as the record date to determine the eligibility of Quality Care India Limited shareholders for the allotment of equity shares pursuant to the Scheme of Amalgamation. The Board of Directors approved this date during its meeting held on June 25, 2026, following the National Company Law Tribunal (NCLT), Hyderabad Bench, order dated June 19, 2026. The scheme facilitates the merger of Quality Care India Limited with Aster DM Healthcare Limited.

The share exchange ratio for the amalgamation is set at 977 fully paid-up equity shares of Aster DM Healthcare Limited, each with a face value of INR 10, for every 1,000 equity shares held in Quality Care India Limited. The entitlement of shareholders will be determined based on their holdings on the record date. The NCLT approved the scheme under Sections 230 to 232 of the Companies Act, 2013.

Key Details of the Amalgamation

The following table outlines the primary entities and the specific terms of the scheme:

The Scheme of Amalgamation will become effective only after the respective companies file the certified copy of the NCLT order with the Registrar of Companies and satisfy other conditionalities mentioned in the scheme. Upon the scheme becoming effective, Quality Care India Limited shall stand dissolved without winding up. Aster DM Healthcare Limited will inform the stock exchanges about the Effective Date of the scheme in due course. The intimation was submitted to the BSE Limited and the National Stock Exchange of India Ltd in compliance with Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.